Publications found:
178
Sort by:
Biosensor Diagnostics Market Forecasts to 2034 – Global Analysis By Product Type (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, Nanomechanical Biosensors, Wearable Biosensors, and Other Product Types), Technology, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Biosensor Diagnostics Market is accounted for $28.6 billion in 2026 and is expected to reach $89.4 billion by 2034 growing at a CAGR of 15.3% during the foreca...
April 2026
200 pages
Rapid Tests Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Others), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global rapid tests market size was estimated at USD 12.76 billion in 2025 and is projected to reach USD 19.30 billion by 2033, growing at a CAGR of 5.31% from 2026 to 2033. The growth can be attri...
April 2026
130 pages
Lateral Flow Assay Market Report by Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Product (Kits and Reagents, Lateral Flow Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety and Environment Testing, Drug Development and Quality Testing), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical and Biotechnology Companies, and Others), and Region 2026-2034
US$ 2,999.00
The global lateral flow assay market size reached USD 11.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.00%...
April 2026
145 pages
Pregnancy Detection Kits Market Report by Product (Home Pregnancy Tests (HPT), Digital Devices, and Others), Test Type (Urine Test for HCG, Blood Test for HCG, and Others), End User (Household, Gynecology Clinics, Hospitals), and Region 2026-2034
US$ 2,999.00
The global pregnancy detection kits market size reached USD 1.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5....
April 2026
141 pages
Point of Care Molecular Diagnostics Market Report by Product and Service (Assays and Kits, Instruments and Analyzers, Software and Services), Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Others), End User (Physicians’ Offices, Hospitals and ICUs, Research Institutes, and Others), and Region 2026-2034
US$ 2,999.00
The global point of care molecular diagnostics market size reached USD 4.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2034, exhibiting a growth rate (...
April 2026
141 pages
Pregnancy Point of Care Testing Market - 2025-2033
US$ 2,999.00
The Pregnancy Point of Care Testing Market was valued at US$ 2.68 billion in 2025 and is anticipated to reach US$ 4.35 billion by 2033, at a CAGR of 0.064 from 2026 to 2032. The report delivers in-dep...
March 2026
200 pages
Asia Pacific Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy And Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
US$ 3,450.00
The Asia Pacific Point of Care (POC) Diagnostics Market is poised for significant growth, with projections indicating that it will reach approximately US$ 22,950.4 million by 2031, up from US$ 8,521.7...
March 2026
202 pages
Europe Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
US$ 3,450.00
The Europe Point of Care (POC) Diagnostics Market is projected to grow significantly, reaching an estimated US$ 21,407.3 million by 2031, up from US$ 8,939.5 million in 2024. This growth represents a...
March 2026
203 pages
Middle East & Africa Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy And Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
US$ 3,450.00
The Middle East and Africa Point of Care (POC) Diagnostics Market is projected to grow significantly, reaching an estimated US$ 3,524.0 million by 2031, up from US$ 1,670.9 million in 2024. This growt...
March 2026
186 pages
North America Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
US$ 3,450.00
The North America Point of Care (POC) Diagnostics Market is projected to experience substantial growth, with an expected market size of approximately US$ 34,026.8 million by 2031, up from US$ 15,289.0...
March 2026
180 pages
South & Central America Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
US$ 3,450.00
The South & Central America Point of Care (POC) Diagnostics Market is projected to grow significantly, reaching an estimated US$ 6,924.0 million by 2031, up from US$ 3,508.9 million in 2024. This grow...
March 2026
179 pages
Self-testing Market Size, Share & Trends Analysis Report By Product (Kits, Device, Strips), By Sample (Blood, Urine, Stool), By Application, By Distribution Channel, By Usage, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global self-testing market size was estimated at USD 11.78 billion in 2025 and is expected to reach USD 21.92 billion by 2033, growing at a CAGR of 8.46% from 2026 to 2033. This growth is driven b...
March 2026
160 pages
Japan Point-of-Care Diagnostics Market - 2024-2033
US$ 2,999.00
The Japan Point-of-Care Diagnostics Market was valued at US$ 832.04 million in 2024 and is anticipated to reach US$ 1,925.62 million by 2033, at a CAGR of 0.098 from 2026 to 2032. The report delivers...
February 2026
223 pages
Global Molecular POCT Reagents Market Growth 2026-2032
US$ 3,660.00
The global Molecular POCT Reagents market size is predicted to grow from US$ 3914 million in 2025 to US$ 7345 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032. Molecular POC...
January 2026
103 pages
Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring products, Covid-19 Test Products, Others), By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), By Mode Of Purchase (Prescription Based Products, OTC Products), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Point of Care Diagnostics Market is projected to expand from USD 49.89 Billion in 2025 to USD 84.83 Billion by 2031, registering a compound annual growth rate of 9.25%. Defined as medical t...
January 2026
180 pages
Point-of-care Biosensors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Glucose Monitoring, HIV, Hepatitis C, Pregnancy), By Platforms (Microfluidics, Dipsticks, Immunoassays), By End User (Hospitals & Clinics, Pharmacy, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Point-of-care Biosensors Market is projected to expand from USD 81.56 Billion in 2025 to USD 130.22 Billion by 2031, reflecting a CAGR of 8.11%. These biosensors serve as critical analytica...
January 2026
185 pages
Point-Of-Care Molecular Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other), By Test Location (OTC, POC), By End User (Decentralized Labs, Hospitals, Home-care, Assisted Living Healthcare Facilities, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Point-Of-Care Molecular Diagnostics Market is projected to experience significant growth, rising from a valuation of USD 2.88 Billion in 2025 to USD 5.45 Billion by 2031, reflecting a CAGR...
January 2026
186 pages
Rapid Test Kit Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type (Rapid Antigen Test v/s Rapid Antibody Test), By Product Type (Over-the-counter {OTC} Rapid Test Kit v/s Professional Rapid Test Kit), By Technology (Lateral Flow Assays, Solid Phase, Agglutination, Immunospot Assay), By Duration (Less than 30 Minutes, Less than 10 Minutes, Less than 1 Hour, 1 Hour - 2 Hour, Others), By Application (Infectious Disease, Glucose Monitoring, Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others), By End User (Hospitals & Clinics, Home Care, Diagnostic Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Rapid Test Kit Market is projected to expand from USD 28.36 Billion in 2025 to USD 50.38 Billion by 2031, achieving a CAGR of 10.05%. This industry focuses on disposable diagnostic devices...
January 2026
180 pages
Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End Use (Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... in large customer base adopting cost-effective and immediate diagnostic tests, propelling the point of care diagnostics/testing market. This is further supplemented by numerous favorable initiatives to promote the ...
January 2026
300 pages
The 2027-2032 World Outlook for Rapid Diagnostic Test Kits
US$ 1,195.00
This study covers the world outlook for rapid diagnostic test kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Clinical Testing, Veterinary Diagnostics), By Technique (Sandwich, Competitive), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global lateral flow assays (LFA) market size was estimated at approximately USD 10.17 billion in 2025 and is projected to reach USD 17.44 billion by 2033, growing at a CAGR of 7.41% from 2026 to...
December 2025
176 pages
Rapid Point-of-Care Testing For Sickle Cell Anemia Market Size, Share & Trends Analysis Report By Type (Lateral Flow Immunoassay, Paper-Based Rapid Diagnostics), By Technology, By Age Group, By Sector Type, By Distribution Channel, By End-use, By Region, And Segment Forecast, 2026 - 2033
US$ 5,950.00
The global rapid point-of-care testing for sickle cell anemia market size was estimated at USD 328.69 million in 2025 and is projected to reach USD 735.35 million by 2033, growing at a CAGR of 10.91%...
December 2025
150 pages
North America Point-of-Care Diagnostics Market - 2024-2033
US$ 2,999.00
The North America Point-of-Care Diagnostics Market was valued at US$ 6.74 billion in 2024 and is anticipated to reach US$ 13.25 billion by 2033, at a CAGR of 0.079 from 2026 to 2032. The report delive...
December 2025
243 pages
Neonatal Point of Care Testing Market - 2023-2031
US$ 2,999.00
The Neonatal Point of Care Testing Market was valued at US$ 971 million in 2023 and is anticipated to reach US$ 2,273 million by 2031, at a CAGR of 0.115 from 2026 to 2032. The report delivers in-dept...
November 2025
220 pages
POC Molecular Diagnostics Market - 2023-2031
US$ 2,999.00
The POC Molecular Diagnostics Market was valued at US$ 2.68 billion in 2023 and is anticipated to reach US$ 4.17 billion by 2031, at a CAGR of 0.069 from 2026 to 2032. The report delivers in-depth ins...
November 2025
210 pages
Point Of Care Data Management Systems Market 2026
US$ 2,999.00
The Point Of Care Data Management Systems Market was valued at in and is anticipated to reach by , at a CAGR of 0.112 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
243 pages
Rapid Medical Diagnostics Market 2026
US$ 2,999.00
The Rapid Medical Diagnostics Market was valued at in and is anticipated to reach by , at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
207 pages
CRISPR-based POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments/Devices, Assay Kits And Reagents, Software And Connectivity Platforms), By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global CRISPR-based POC diagnostics market size was estimated at USD 502.64 million in 2024 and is projected to reach USD 1,786.56 million by 2033, growing at a CAGR of 15.41% from 2025 to 2033. T...
November 2025
150 pages
Global Point of Care Lipid Test Market - 2025 -2033
US$ 4,350.00
Point-of-Care (POC) Lipid Test Market Size and Trends The global point-of-care (POC) lipid test market reached US$ 0.68 billion in 2023, with a rise to US$ 0.72 billion in 2024, and is expected to rea...
October 2025
180 pages
Point-of-Care Molecular Diagnostics Market by Product & Service (Assays, Instruments, Software), Technology (RT-PCR, INAAT), Sample Type (Blood, Urine), Application (STD, HAI, Hepatitis, Cancer), and End User (Hospitals, Clinics) - Global Forecast to 2030
US$ 4,950.00
The global point-of-care molecular diagnostics market is projected to reach USD 7.09 billion by 2030, from USD 4.30 billion in 2025, with a CAGR of 10.5%. The market is primarily driven by the increas...
September 2025
328 pages
Point of Care Diagnostics - Company Evaluation Report, 2025
US$ 2,650.00
The Point of Care Diagnostics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Point of Care Diagnostics. This quadrant offers a detai...
September 2025
147 pages
Global Lateral Flow Assays Market - 2023-2033
US$ 2,999.00
The Global Lateral Flow Assays Market was valued at US$ 6.92 billion in 2023 and is anticipated to reach US$ 15.68 billion by 2033, at a CAGR of 0.086 from 2026 to 2032. The report delivers in-depth i...
August 2025
210 pages
